Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN109943582A reveals high-efficiency DDC catalysis for dopamine. Offers cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Novel patent CN104447451B offers safer oseltamivir intermediate synthesis avoiding sodium azide with high yield for reliable pharmaceutical intermediates supplier chains.
Patent CN112279880A discloses a photocatalytic method for alpha-thioglycosides. Offers mild conditions and high yields for drug synthesis.
Patent CN106831793B reveals high-yield Beckmann rearrangement for ovarian cancer drug intermediate ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN109851658B reveals one-step L-carnosine synthesis reducing cost and improving supply chain reliability for pharmaceutical intermediates.
Novel one-step enzymatic route for L-carnosine reduces cost and complexity. Reliable supply chain partner for high-purity pharmaceutical intermediates and scalable production.
Patent CN103319483A reveals a green PTC-catalyzed route for Linagliptin intermediates, enabling solvent recovery and cost reduction in API manufacturing.
Discover advanced synthesis routes for potent tetrahydrocarbazole derivatives. Enhance your anti-tuberculosis pipeline with high-yield, scalable pharmaceutical intermediates.
Novel patent CN105315256B enables environmentally friendly manufacturing with high purity. Achieve significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN117535268A reveals high-purity esterase resolution. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalysis.
Patent CN106282134A details KgQR enzyme for high yield synthesis. Offers significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing partners.
Patent CN112813131A reveals a high-efficiency carboxylesterase for producing Edoxaban intermediates with superior substrate tolerance and optical purity.
Patent CN113372315B details a robust method for synthesizing C-glucoside impurities, ensuring reliable supply chains and cost-effective API manufacturing for diabetes treatments.
Patent CN101475491B reveals a mild 3-step nitrone route for high-purity diphenylethylamines, offering significant cost reduction and scalable supply chain advantages for API intermediates.
Patent CN110438194B details a novel lipase F11 for resolving DL-tropine methyl ester with >99% ee. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN106892885A details a safer Ranitidine synthesis route eliminating toxic byproducts, offering cost reduction and supply chain reliability for global buyers.
Patent CN102876734B details a novel carbonyl reductase for high-purity chiral alcohol production, offering significant cost and supply chain advantages for API intermediates.
Green synthesis of antitumor pyridoimidazoles via copper catalysis. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN111500652A reveals a novel enzymatic dynamic kinetic resolution for florfenicol. Discover cost-effective, high-purity veterinary drug intermediate manufacturing solutions.
Patent CN102260298B details a high-yield synthesis of key capecitabine intermediates using inosine, offering significant cost reduction and supply chain reliability for manufacturers.